Production & Manufacturing
Fine & Speciality Chemicals

Fine & Speciality Chemicals News

View news from other Pharmaceutical sectors:
76-90 of 422 results
AFC upgrades facilities to manufacture Schedule II controlled substances
By PBR Staff Writer
AMPAC Fine Chemicals (AFC) has been granted Registration as a Manufacturer of Controlled Substances from the US Drug Enforcement Agency (DEA).
Production & Manufacturing > Fine & Speciality Chemicals > News
Kadmon enters agreement with Chiromics for chemical compounds library
By PBR Staff Writer
US-based pharmaceutical company, Kadmon and Chiromics have inked a deal under which Kadmon has secured a non-exclusive license for use of Chiromics' chemical compound libraries that enable discovery and development of pharmaceutical products.
Production & Manufacturing > Fine & Speciality Chemicals > News
Enzymotec wins new patent for Omega-sterol ingredient
By PBR Staff Writer
Enzymotec has won Australian patent for its Omega-sterols ingredient, a hybrid of phytosterols and omega-3s.
Production & Manufacturing > Fine & Speciality Chemicals > News
IMCD to acquire Organotec fine chemicals business in Italy
By PBR Staff Writer
IMCD Italia, a subsidiary of specialty chemical and food ingredients distributor IMCD Group, has agreed to acquire the Organotec's fine chemicals distribution business in Italy.
Production & Manufacturing > Fine & Speciality Chemicals > News
Ideal Cures releases new film coating materials
By PBR Staff Writer
Indian excipient manufacturing company, Ideal Cures, has launched a new range of film coating materials under Instacoat E Series.
Production & Manufacturing > Fine & Speciality Chemicals > News
Ajinomoto plans expansion of feed amino Acids capacity
By PBR Staff Writer
Ajinomoto Animal Nutrition Group (AANG) is all set to expand the production capacity of feed-use amino acids.
Production & Manufacturing > Fine & Speciality Chemicals > News
Oxea to set up oxo derivatives plant in China
By PBR Staff Writer
Oxea, a chemical company is set to establish its first chemical plant to produce oxo derivatives in Nanjing, China, in 2012.
Production & Manufacturing > Fine & Speciality Chemicals > News
Naturex acquires Burgundy Botanical Extracts
By PBR Staff Writer
Naturex, a manufacturer of specialty ingredients, has acquired Burgundy Botanical Extracts, a French manufacturer and supplier of plant extracts for the nutraceutical and pharmaceutical industries.
Production & Manufacturing > Fine & Speciality Chemicals > News
US imposes ban on bath salts chemicals
By PBR Staff Writer
The Drug Enforcement Administration (DEA) in US, has temporarily banned chemicals used in a new type of street drug known as bath salts.
Production & Manufacturing > Fine & Speciality Chemicals > News
WuXi acquires Abgent
By PBR Staff Writer
WuXi PharmaTech has acquired Abgent, a provider of biological research reagent products and services in Suzhou, China, and San Diego, California.
Production & Manufacturing > Fine & Speciality Chemicals > News
ProMetic receives resin supply order from Octapharma
By PBR Staff Writer
Prometic Life Sciences, a biopharmaceutical company, has received $0.73m follow-on purchase order under its supply agreement with Octapharma, a Swiss based plasma fractionation company.
Production & Manufacturing > Fine & Speciality Chemicals > News
Sartorius introduces Sartobind pico with 0.08 ml
By PBR Staff Writer
Sartorius Stedim Biotech, a provider of services for production processes of the biopharmaceutical industry, has added Sartobind pico with 0.08 ml to its salt-tolerant membrane adsorbers line.
Production & Manufacturing > Fine & Speciality Chemicals > News
Sinclair, Invida launch Sinclair dermatology prodcuts in Asia-Pacific
By PBR Staff Writer
UK-based Sinclair has partnered with Invida, known for commercialisation of healthcare products, to launch dermatology brands by Sinclair in seven Asia-Pacific markets.
Production & Manufacturing > Fine & Speciality Chemicals > News
Berkshire Hathaway acquires Lubrizol
By PBR Staff Writer
Berkshire Hathaway has acquired Lubrizol, a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets, for $135 per share.
Production & Manufacturing > Fine & Speciality Chemicals > News
EFCG endorses new Generic Drug User Fees Act by FDA
By PBR Staff Writer
European Fine Chemicals Group (EFCG), the representative body for European manufacturers of fine chemicals, has agreed to authorize the proposal of the US Food and Drug Administration (FDA) to put forward a legislative package, designed with the help of EFCG and US industry representatives, to deliver into US law a new Generic Drug User Fees Act (GDUFA).
Production & Manufacturing > Fine & Speciality Chemicals > News
76-90 of 422 results